Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Profit After Tax: 2010-2025

Historic Profit After Tax for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Sep 2025 value amounting to $40.1 million.

  • Ironwood Pharmaceuticals' Profit After Tax rose 999.29% to $40.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.5 million, marking a year-over-year increase of 1014.74%. This contributed to the annual value of $880,000 for FY2024, which is 100.09% up from last year.
  • As of Q3 2025, Ironwood Pharmaceuticals' Profit After Tax stood at $40.1 million, which was up 69.84% from $23.6 million recorded in Q2 2025.
  • Ironwood Pharmaceuticals' Profit After Tax's 5-year high stood at $391.3 million during Q2 2021, with a 5-year trough of -$1.1 billion in Q2 2023.
  • Its 3-year average for Profit After Tax is -$91.2 million, with a median of $2.3 million in 2024.
  • Its Profit After Tax has fluctuated over the past 5 years, first slumped by 3,038.18% in 2023, then skyrocketed by 2,844.07% in 2025.
  • Ironwood Pharmaceuticals' Profit After Tax (Quarterly) stood at $41.4 million in 2021, then rose by 18.11% to $48.9 million in 2022, then tumbled by 103.57% to -$1.7 million in 2023, then spiked by 229.28% to $2.3 million in 2024, then surged by 999.29% to $40.1 million in 2025.
  • Its Profit After Tax was $40.1 million in Q3 2025, compared to $23.6 million in Q2 2025 and -$37.4 million in Q1 2025.